Potential Therapeutic Targets for UV-Induced Skin Carcinogenesis Associated with HPV38 Infection
Vinh Nguyen
Introduction: Keratinocyte carcinoma, comprised of cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC), are the most frequently diagnosed cancers in the Western world.1 Ultraviolet (UV) radiation is the overwhelming causative environmental carcinogen in keratinocyte carcinoma.1 Histopathology is the gold standard for the diagnosis of cSCC, and surgery remains the mainstay of treatment for invasive keratinocyte carcinoma.2 Beta human papillomavirus (βHPV) DNA may play a role at the beginning of the tumorigenic process, facilitating the accumulation of UV-induced DNA mutations.3 The early region of the genome contains viral oncogenes E6 and E7.4 These oncoproteins target tumor-suppressor proteins for proteasomal degradation, which leads to suppression of apoptosis and promotion of cellular proliferation.4 This gives HPV its carcinogenic potential.4 Once UV-induced DNA damage becomes irreversible, the infected cell can progress towards transformation, and the expression of E6 and E7 is dispensable for the maintenance of the malignant phenotype.5 This behavior has been described as “hit-and-run.”3,5 This paper aims to explore the mechanisms behind this behavior and potential therapeutic targets. Methods: PHKs expressing human telomerase reverse transcriptase gene (hTERT) were transduced with a recombinant pLXSN retroviral vector encoding HPV38 E6 and E7.6 These hTERT PHKs were then UVB irradiated and compared with hTERT PHKs transduced with an empty control vector that was also UVB irradiated.6 Total RNA was extracted, and TLR9 and viral mRNA levels were analyzed by RT-qPCR.6 In a second experiment, in order to examine ITGA1, PHKs were transduced with pLXSN HPV38 oncoprotein E6 and E7 or the empty retroviral vector pLXSN.7 mRNA levels were measured by RT-qPCR.7 In a third experiment, K14-HPV38 E6/E7Tg mice were crossed with PycardKO mice (Pycard encodes ASC).8 Littermates not crossed with PycardKO were used as controls.8 Results: TLR9 expression levels and TLR9 protein levels in HPV38 E6 and E7 hTERT PHKs were lower compared to the control cells.6 ChIP experiments showed that E6 and E7 significantly affected p53 recruitment to the TLR9 promoter.6 This indicates that E6 and E7 can prevent UV-mediated activation of TLR9 expression.6 In the second experiment, the expression levels of ITGA1, a repressor of epidermal growth factor receptor signaling, were significantly downregulated by the oncoproteins.7 In the third experiment, the K14-HPV38 E6/E7Tg mice crossed with PycardKO mice developed skin tumors significantly quicker than the littermate controls, which provides evidence that ASC provides a protective advantage against UV-induced skin carcinogenesis.8 Conclusion: Together, these studies provide evidence that TLR9, ITGA1, and ASC can be potential therapeutic targets in preventing UV-induced skin carcinogenesis associated with HPV38 infection.
- Nagarajan P, Asgari MM, Green AC, et al. Keratinocyte Carcinomas: Current Concepts and Future Research Priorities. Clin Cancer Res. 2019;25(8):2379-2391. doi:10.1158/1078-0432.CCR-18-1122
- Combalia A, Carrera C. Squamous Cell Carcinoma: An Update on Diagnosis and Treatment. Dermatol Pract Concept. 2020;10(3):e2020066. doi:10.5826/dpc.1003a66
- Viarisio D, Müller-Decker K, Accardi R, et al. Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice. PLoS Pathog. 2018;14(1):e1006783. doi:10.1371/journal.ppat.1006783
- Bacik LC, Chung C. Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature. Int J Dermatol. 2018;57(6):627-634. doi:10.1111/ijd.13819
- Tommasino M. HPV and skin carcinogenesis. Papillomavirus Res. 2019;7:129-131. doi:10.1016/j.pvr.2019.04.003
- Pacini L, Ceraolo MG, Venuti A, et al. UV Radiation Activates Toll-Like Receptor 9 Expression in Primary Human Keratinocytes, an Event Inhibited by Human Papillomavirus 38 E6 and E7 Oncoproteins. J Virol. 2017;91(19):e01123-17. doi:10.1128/JVI.01123-17
- Romero-Medina MC, Venuti A, Melita G, et al. Human papillomavirus type 38 alters wild-type p53 activity to promote cell proliferation via the downregulation of integrin alpha 1 expression. PLoS Pathog. 2020;16(8):e1008792. doi:10.1371/journal.ppat.1008792
- Magnotti F, Valsesia S, Gupta P, et al. The Inflammasome Adaptor ASC Delays UV-Induced Skin Tumorigenesis in Beta HPV38 E6 and E7 Transgenic Mice. J Invest Dermatol. 2021;141(1):236-238.e2. doi:10.1016/j.jid.2020.04.028